What are the best medications for treating Restless Leg Syndrome (RLS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medications for Restless Leg Syndrome (RLS)

Alpha-2-delta ligands (gabapentin, pregabalin, gabapentin enacarbil) are the first-line treatment for Restless Leg Syndrome, with iron supplementation recommended for patients with low ferritin levels or transferrin saturation. 1

First-Line Treatments

Alpha-2-delta Ligands

  • Gabapentin, pregabalin, and gabapentin enacarbil are recommended as first-line treatments for RLS 1
  • Gabapentin is specifically recommended for patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) 2, 1
  • These medications do not cause augmentation (worsening of symptoms over time), which is a significant advantage over dopaminergic agents 3
  • Possible side effects include sedation and dizziness 3

Iron Supplementation

  • Recommended for patients with ferritin ≤75 ng/mL or transferrin saturation <20% 1
  • IV ferric carboxymaltose has a strong recommendation for patients with iron deficiency 1
  • For ESRD patients with RLS, IV iron sucrose is recommended if ferritin <200 ng/mL and transferrin saturation <20% 2, 1

Second-Line Treatments

Dopaminergic Agents (Short-term Use Only)

  • The AASM suggests against the standard use of dopaminergic agents including levodopa, pramipexole, ropinirole, and rotigotine due to risk of augmentation with long-term use 2
  • These medications may be considered for short-term use in patients who prioritize immediate symptom relief over long-term side effects 2
  • Ropinirole has shown efficacy in clinical trials with significant improvements in RLS symptoms and sleep quality 4, 5
  • However, augmentation (earlier occurrence and worsening of symptoms) is a major limitation with long-term use 3

Opioids

  • Extended-release oxycodone may be considered for severe to very severe RLS as a second-line option 1
  • Limited evidence for routine use 3

Special Populations

End-Stage Renal Disease Patients

  1. Gabapentin (first-line) 2, 1
  2. IV iron sucrose (if ferritin <200 ng/mL and transferrin saturation <20%) 2, 1
  3. Vitamin C supplementation 2, 1
  4. Consider cool dialysate for patients on hemodialysis 1

Medications to Avoid in RLS

  • Bupropion 2
  • Carbamazepine 2
  • Clonazepam 2
  • Valproic acid 2
  • Cabergoline (strong recommendation against) 2
  • Valerian 2

Non-Pharmacological Approaches

  • Regular exercise appropriate to patient capabilities 1
  • Good sleep hygiene practices (consistent sleep-wake schedule, limiting stimulants) 1
  • Bilateral high-frequency peroneal nerve stimulation 1
  • Aerobic resistance exercise for physically capable patients 1

Important Clinical Considerations

  • Eliminate or reduce alcohol and caffeine consumption 1
  • Discontinue medications that may worsen RLS (antipsychotics, certain antidepressants, dopamine antagonists, some antihistamines) 1
  • Treat untreated obstructive sleep apnea 1
  • Monitor for side effects and treatment response regularly 1

Treatment Algorithm

  1. Check ferritin and transferrin saturation levels
  2. If iron deficient, start iron supplementation (oral or IV based on severity)
  3. For primary pharmacological treatment, start with alpha-2-delta ligands
  4. If inadequate response, consider short-term dopaminergic agents with careful monitoring for augmentation
  5. For severe cases not responding to above treatments, consider opioids
  6. Implement non-pharmacological approaches concurrently

This approach prioritizes treatments with the best long-term safety profiles while effectively managing RLS symptoms and improving quality of life.

References

Guideline

Restless Legs Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of restless legs syndrome.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014

Research

Ropinirole for the treatment of restless legs syndrome.

Neuropsychiatric disease and treatment, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.